Maternal and Fetal Health is part of the Developmental Biomedicine Research Group within the School of Medicine
Maternal and Fetal Health

News archive 2008

2008

Three Tommy's Funded Research Conference

This research conference was organised in October as an opportunity to bring together staff and students from the 3 Tommy's funded Research Centres in Manchester, London and Edinburgh; to showcase the Research Centre portfolios, to establish collaborations and to discuss ideas for a 3 Centre Research Strategy. The programme included presentations from young investigators from all 3 Centres - focusing on complications of pregnancy, lifestyle factors affecting pregnancy outcome and animal models and programming. These were supported by a poster session that focused on techniques and methodology used in research.

This was the first 3 Centre Conference which demonstrated our ambitious spirit to conduct interdisciplinary research that helps us to find solutions to pregnancy problems, and was a fantastic platform for drawing the national Tommy's network together to improve the translation of this into treatment for women and their babies.

'Statins are detrimental to human placental development and function: use of statins during early pregnancy is inadvisable'
Manuscript by Karen Forbes, Lucy M Hurst, J Martin Gibson, John D Aplin and Melissa Westwood has been accepted for publication in the Journal of Cellular and Molecular Medicine.

The diabesity epidemic will lead to an increase in the treatment of women of reproductive age with statins (HMG CoA reductase inhibitors). This research - conducted by researchers in the Maternal and Fetal Health Research Group and Genomics Research - has shown that such drugs are detrimental to the early development of the human placenta. Given that reduced placental growth is strongly correlated with poor pregnancy outcome, statins should not be used by women planning to start a family or once a pregnancy is suspected or confirmed.

Studentship awards

Summer studentships